findmyKOL

Jonathan Meyer, MD

Enriched profile

Clinical Professor (Voluntary), Department of Psychiatry · University of California, San Diego (UC San Diego)

ORCIDNone on fileNPI↗
✓ Full profile
Region🇺🇸 San Diego, CA · West · United StatesSpecialtyPsychiatryFocusSchizophrenia
Active KOLLatest publicationNone indexedOnline presenceverified 2026Payments2021–2025NIH funding2005–2010Why? →

Jonathan Meyer is Clinical Professor (Voluntary), Department of Psychiatry at University of California, San Diego (UC San Diego). ClinicalTrials.gov lists 4 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 22 Oct 2026

Jonathan M. Meyer, MD, is Clinical Professor (Voluntary), Department of Psychiatry at University of California, San Diego (UC San Diego). The public record shows 15 publications with 2,482 citations (h-index 10), centered on Schizophrenia. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 25 companies, 3 NIH-funded awards (2005–2010).

  • Top research focus: Schizophrenia
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 25 companies

Generated from the cited public record · current as of 22 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Schizophrenia2 trialsInsulin Resistance1 trialMetabolic Syndrome1 trial

Research focus

OpenAlex concept fingerprint
Schizophrenia

Drugs & molecules

across trials, industry payments and publications
Lybalvigeneric · Olanzapine / samidorphanClinical trials—Industry payments929Publications—Aristadageneric · Aripiprazole lauroxilClinical trials—Industry payments820Publications—Caplytageneric · LumateperoneClinical trials—Industry payments365Publications—Ingrezzageneric · ValbenazineClinical trials—Industry payments303Publications—Uzedygeneric · RisperidoneClinical trials—Industry payments198Publications—Vraylargeneric · CariprazineClinical trials—Industry payments188Publications—Auvelitygeneric · Bupropion / dextromethorphanClinical trials—Industry payments123Publications—Cobenfygeneric · Trospium / xanomelineClinical trials—Industry payments99Publications—Austedogeneric · DeutetrabenazineClinical trials—Industry payments48Publications—Secuadogeneric · AsenapineClinical trials—Industry payments8Publications—AripiprazoleClinical trials—Industry payments6Publications—PaliperidoneClinical trials—Industry payments6Publications—

Works with

trial sponsors and companies reporting payments
Alkermes, Inc.Clinical trials—Industry payments400Neurocrine BioSciences, Inc.Clinical trials—Industry payments305Teva Pharmaceuticals USA, Inc.Clinical trials—Industry payments303ITI, Inc.Clinical trials—Industry payments205Abbvie Inc.Clinical trials—Industry payments198ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)Clinical trials—Industry payments160E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments128Axsome Therapeutics, Inc.Clinical trials—Industry payments126Otsuka Pharmaceutical Development & Commercialization, Inc.Clinical trials—Industry payments9Noven Pharmaceuticals, Inc.Clinical trials—Industry payments8ACADIA Pharmaceuticals IncClinical trials—Industry payments7Luye Pharma (USA) Ltd.Clinical trials—Industry payments6Sunovion Pharmaceuticals Inc.Clinical trials—Industry payments6Veterans Medical Research FoundationClinical trials4Industry payments—Otsuka America Pharmaceutical, Inc.Clinical trials—Industry payments3Avadel CNS Pharmaceuticals, LLCClinical trials—Industry payments2Supernus Pharmaceuticals, Inc.Clinical trials—Industry payments2Abbott LaboratoriesClinical trials—Industry payments1Biogen, Inc.Clinical trials—Industry payments1Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments1Janssen Pharmaceuticals, IncClinical trials—Industry payments1Janssen Scientific Affairs, LLCClinical trials—Industry payments1Sumitomo Pharma America, Inc.Clinical trials—Industry payments1Tris Pharma IncClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
10h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
25companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
3NIH grants · 2005–2010

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 22 Oct 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

All 4 trial records: search, sort and filter.Explore →

Industry payments

Updated 22 Oct 2026

25 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 54 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

NIH funding

Updated 22 Oct 2026

3 NIH research awards on record, funded 2005–2010 per NIH RePORTER. The latest:

All 13 award records: search, sort and filter.Explore →

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Online presence

Updated 22 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/jonathan-meyer-md-7d907b8a

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • ResearchGate

    researchgate.net/profile/Jonathan-Meyer-5

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Other

    psychopharmacologyinstitute.com/author/jonathan-m-meyer-878

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →psychopharmacologyinstitute.com ↗
  • Other

    hmpglobalevents.com/faculty/psych-congress-np-institute/920

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hmpglobalevents.com ↗
  • Other

    mdedge.com/podcasts/psychcast/lumateperone-treating-schizophrenia-dr-jonathan-meyer

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdedge.com ↗
  • Other

    psychiatrictimes.com/authors/jonathan-m-meyer-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatrictimes.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 22 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Chief Editor

    "Medical Illness and Schizophrenia" (2nd edition)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →media.mycme.com ↗
  • Deputy Editor

    Current Psychiatry

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →curesz.org ↗
  • Chair

    CLOSZE Panel (Clozapine in Schizophrenia Experts)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →curesz.org ↗
  • Sole author

    "Pharmacotherapy of Psychosis and Mania" chapter, Goodman & Gilman's The Pharmacological Basis of Therapeutics (last 3 editions)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →expertperspectives.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
  • AJMC

    "AMCP 2011: Interview with Dr. Jonathan Meyer of the University of California at San Diego"

    2011
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ajmc.com ↗
  • Medscape InDiscussion

    "Treatment-Resistant Schizophrenia," S2 Episode 1

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medscape.com ↗
  • HCPLive video interview

    "Cognitive Gains, Dopamine-Free Schizophrenia Treatment with Xanomeline Trospium Chloride"

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗
  • Psychiatry & Psychotherapy Podcast

    Episode 127, "Using Antipsychotic Plasma Levels: Insights from Jonathan Meyer on Therapeutic Thresholds"

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatrypodcast.com ↗
  • The Gus Alva Perspective: SoCal Psych

    "Schizophrenia Preview, with Jonathan Meyer, MD" (YouTube)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.